MedPath

A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis

Phase 4
Completed
Conditions
Hyperhidrosis
Interventions
Biological: Botulinum Toxin Type A
Registration Number
NCT00168415
Lead Sponsor
Allergan
Brief Summary

A study using Botulinum Toxin Type A in adolescents with axillary hyperhidrosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
144
Inclusion Criteria
  • Marked axillary hyperhidrosis
Exclusion Criteria
  • Previous use of botulinum toxin for hyperhidrosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Botulinum Toxin Type ABotulinum Toxin Type A
Primary Outcome Measures
NameTimeMethod
Subject's assessment of the severity of hyperhidrosis using the HDS ScaleMonthly
Secondary Outcome Measures
NameTimeMethod
Measurement of axillary sweat productionWeek 4, Week 8 and any re-injection visit
© Copyright 2025. All Rights Reserved by MedPath